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Abstract: Clostridium difficile, a leading cause of hospital-acquired infection, possesses a dense 
surface layer (S-layer) that mediates host-pathogen interactions. The key structural components of the 
S-layer result from proteolytic cleavage of a precursor protein, SlpA, into high- and low-molecular-
weight components. Here we report the discovery and optimization of the first inhibitors of this 
process in live bacteria, and their application for probing S-layer processing. We also describe the 
design and in vivo application of activity-based probes that identify the protein Cwp84 as the cysteine 
protease that mediates SlpA cleavage. This work provides novel chemical tools for the analysis of S-
layer biogenesis, and for the potential identification of novel drug targets within clostridia and related 
bacterial pathogens. 
INTRODUCTION 
Clostridium difficile is a Gram-positive antibiotic-resistant anaerobe that can cause severe 
gastrointestinal disease in humans (1, 2) and livestock (3), and is a leading cause of hospital-acquired 
infection (4). The C. difficile cell is completely coated by the surface layer (S-layer), a paracrystalline 
proteinacious array that mediates host-pathogen interactions (5, 6). Previously we have shown that the 
key structural components of the S-layer are the result of proteolytic cleavage of a precursor protein, 
SlpA, into high- and low-molecular-weight components, namely the HMW and LMW S-layer 
proteins (SLPs) (5). These proteins reassemble to form the hexagonal S-layer lattice, and recently we 
reported the structure of the resultant HMW/LMW SLP complex (7). It is estimated that during 
exponential growth up to 400 molecules of SlpA per cell per second are synthesized, translocated to 
the S-layer and cleaved (8), indicating an acute demand for LMW and HMW SLPs in the expanding 
S-layer. The cleavage site in SlpA is widely conserved across many clinical strains of C. difficile, 
suggesting a similarly conserved protease is responsible for the processing event. Whilst constitutive 
gene knockouts can be achieved in C. difficile using the elegant ClosTron system (9), there is no 
reliable technique for achieving conditional knockouts, and despite widespread efforts it has not 
proven possible to generate a SlpA knockout strain to date. We hypothesized that a chemical genetic 
approach exploiting specific protease inhibitors and activity-based probes (ABPs) could be a powerful 
approach for the study of SlpA processing in vivo. Here we report the discovery of the first inhibitors 
of S-layer processing in live C. difficile cells, and the development of activity-based probes that 
enable detection and identification of the protease responsible for S-layer processing. 
^ SCHEME 1 
RESULTS AND DISCUSSION 
The cleavage products of SlpA may be observed directly by sodium dodecyl sulfate polyacrylamide 
gel electrophoresis (SDS-PAGE) followed by Western blot analysis of the total S-layer fraction 
against an anti-LMW SLP antibody (7). Screening a panel of commercially-available protease 
inhibitors in this in vivo assay against the C. difficile reference strain 630 revealed that E-64 (Fig. 1A) 
has a modest inhibitory effect on SlpA processing at 100 µM, as shown by the appearance of 
unprocessed SlpA at 74 kDa apparent molecular weight (Fig. 1B). E-64 represents the first known 
inhibitor of S-layer processing in C. difficile; it is a natural product first isolated from Aspergillus 
japonicas, and is a broad-spectrum irreversible inhibitor of papain cysteine proteases (10). Further 
investigations demanded facile access to inhibitor analogues, and a flexible solid-phase synthetic 
route (Scheme S1) was therefore used to generate epoxide 1, a peptidic analogue of E-64 (11). 1 
retains the N-terminal trans-(S,S)-epoxysuccinyl moiety, which was appended to a Leu-Arg dipeptide 
amide, recapitulating the key stereochemistry and functionality of the natural product (Fig. 1A). 1 was 
found to possess identical activity to E-64 in the in vivo assay (Fig. 1B), as does ethyl ester 2, the 
synthetic precursor to 1. Analogues in which the warhead epoxide is in the (R,R) configuration or in 
which the epoxysuccinyl group is replaced with an acetyl group are inactive in vivo (data not shown), 
demonstrating a highly stereoselective mode of action and confirming the requirement for the 
electrophilic warhead. The activity of 1 was further measured across a panel of seven clinical C. 
difficile strains in addition to 630 with a broad range of sequence variation around the cleavage site of 
SlpA (Table S1). Activity was closely comparable (Fig. S1A), strongly suggesting a conserved mode 
of action across all these strains. 
^ FIGURE 1 
With this evidence in hand we sought to explore the structure-activity relationship for this 
class of inhibitors, as a precursor to identifying the target enzyme. Little is known about expression 
and activity of proteases in C. difficile and to date only a handful has been characterized to any 
degree. Activity based probes (ABPs) are a powerful tool for the de novo identification of enzymes, 
particularly in organisms that lack facile genetic tools (12, 13). However, there are relatively few 
examples of the application of ABPs to bacterial systems (14-19), and their use in C. difficile is 
without precedent to date. A series of ABPs based on 1 were designed by appending L-propargyl 
glycine (Pra) to an expanded library of inhibitors with the objective of identifying their target and, by 
extension, the protease that mediates S-layer processing. The alkyne motif in Pra provides a small 
chemical tag that is expected to have minimal effect on distribution and binding to the target enzyme, 
and can be addressed by a selective bioorthogonal ligation reaction to enable subsequent addition of 
labels for detection (12, 20-22). A panel of probes 3-17 was synthesized, each featuring a different 
amino acid motif in the targeting element (Fig. 1A), and tested in vivo against 630 at 100 µM, 
revealing a striking pattern of inhibitory activity (Fig. 2A). 3 (LR) had identical activity to E-64 and 
the parent inhibitor 1, as expected. However, 5 (F) had equal activity, whilst 9 (Y) and 13 (R) showed 
significantly improved potency over E-64 and 1; the remaining analogues 4, 6-8, 10-12 and 14-16 (A, 
I, L, V, S, H, K, E, G, P) had no detectable activity under the conditions tested. This interesting 
structure-activity relationship in which both positively charged and large aromatic residues are 
permitted can be rationalized by examining the conservation of the SlpA cleavage site across C. 
difficile strains (Table S1). On the basis of our previously published data (23, 24), the P2 position (i.e. 
the second residue upstream of the cleavage site) is either Y or K, and we conjecture that these 
inhibitors target a papain class cysteine protease in the canonical mode for E-64 (25, 26), whereby the 
epoxide warhead occupies the P1 position (S or G in most known cleavage sites) and the first amino 
acid in the inhibitor occupies P2. Further testing of 4 (A) and 12 (K) supports this hypothesis, with no 
activity observed for 4 up to 500 µM, and moderate activity at concentrations of 12 above 250 µM 
(Fig. S2). 
We next investigated the dependence of in vivo inhibition on inhibitor concentration (Fig. 
2B). For 3, little effect on S-layer processing was observed below 50 µM. However, 9 (Y) retains 
significant inhibition down to a concentration of 10 µM, indicating an order of magnitude 
improvement in in vivo activity over E-64 and 3. Full-length SlpA continues to accumulate in the S-
layer with increasing concentration of 3, but reaches a plateau at around 500 µM (Fig. 2B). This 
puzzling result was readily rationalized upon examination of the supernatant of inhibited cultures: at 
inhibitor concentrations of 250 µM and above SlpA is shed from cells, eventually reaching levels in 
excess of the total S-layer protein retained on the cell wall (Fig. 2B). This remarkable result indicates 
that unprocessed SlpA is not well-tolerated within the tight matrix of the S-layer, and that inhibited 
cultures upregulate production of SlpA. This may be related to a general stress response, as increased 
slpA expression has been reported in C. difficile exposed to a variety of stresses (27, 28). Notably, 
although inhibition of S-layer processing does not appear to have a direct impact on growth rate in the 
rich media used in these experiments, it has a dramatic effect on cell wall integrity. The cell wall of C. 
difficile grown under normal culture conditions is exceptionally stable, highlighted by the fact that 
boiling cells in a strong anionic detergent (0.7% SDS, 100 °C) does not induce lysis; however, 
inhibited cells are highly sensitive to lysis under these conditions (Fig. S3). 
^ FIGURE 2 
 As shown in Scheme 1, at least two proteases are expected to be involved in the maturation of 
SlpA – the signal peptidase that cleaves the signal sequence responsible for directing translocation to 
the cell surface, and the putative protease that separates the LMW and HMW SLPs. If translocation is 
a prerequisite for subsequent processing, in principle inhibition of either of these proteases could 
result in accumulation of full-length SlpA. However, full-length SlpA is found in the S-layer and 
supernatant fractions in inhibited cells, strongly suggesting that translocation precedes inhibition and 
that the inhibitors described here target the downstream processing step (step B in Scheme 1). We 
next sought to determine the target labeled by these ABPs in live cells, with the aim of identifying the 
protease specific to S-layer processing in C. difficile. Samples from each of the inhibition experiments 
above were visualized by direct in-gel fluorescence following bioorthogonal ligation to a fluorescent 
reporter (Fig. S4). This reagent bears an azide for bioorthogonal ligation using 3+2 copper catalyzed 
azide-alkyne cycloaddition (CuAAC) and a TAMRA fluorophore for sensitive detection of labeled 
proteins by in-gel fluorescence (29, 30). The results from this experiment are striking (Fig. 2C): a 
strongly labeled fluorescent band is observed in direct correlation with ABP activity. A second band 
is observed at slightly higher apparent molecular weight, and is particularly strongly labeled by 13 
(R). Interestingly, weak bands were observed for 6 (I), 8 (V), 11 (H) and 12 (K), suggesting large 
hydrophobic and positivity charged residues may be tolerated to some extent. A number of lower 
molecular-weight bands were more weakly labeled in an inhibition-independent manner, presumably 
due to background CuAAC ligation (Fig. S5). 
Having established that putative targets of these probes reside in the S-layer of C. difficile and 
should be readily accessible to ABPs in the medium we considered that ABPs directly incorporating a 
biotin label would simplify the process of target identification, removing the requirement for two-step 
labeling and eliminating any interference from background CuAAC ligation. Biotin was appended to 
the C-terminus via a short PEG linker by performing solid phase synthesis on Biotin NovaTag resin, 
providing PEG-Biotin labeled ABPs 17 (LR) and 18 (R) (Fig. 1A). These ABPs were found to 
possess identical activity to the parent inhibitors in live cell assays (Fig. 2D), and NeutrAvidin-HRP 
blot of S-layer fractions showed the same strong bands for labeled protein (Fig. 2E). The activity and 
labeling properties of 17 were also conserved across multiple strains of C. difficile (Fig. S1B). 
Labeling experiments on strain 630 were scaled up to provide sufficient protein for identification, and 
affinity purification on NeutrAvidin-agarose followed by elution into loading buffer and SDS PAGE 
enabled the direct visualization of bands by coomassie staining (Fig. 2E). Whilst the labeled bands 
were not visible by coomassie staining prior to enrichment, they were readily identified after pull-
down. The highly abundant LMW and HMW SLPs remain largely in the supernatant, whilst the 
labeled protein co-purifies with a number of unlabelled proteins that have markedly increased 
abundance in enriched samples from cells treated with 17 or 18. 
MALDI-ToF fingerprint analysis against the C. difficile 630 genome revealed that the labeled 
proteins are all members of the cell wall protein family of which the cysteine protease Cwp84 is a 
member. Cwp84 is one of the few proteases previously characterized in C. difficile, and was 
previously reported to have proteolytic activity against various matrix proteins (31, 32). Genomic 
analysis reveals that Cwp84 is encoded in the same genomic region as SlpA (33, 34), and shows 
strong secondary structural homology to papain class cysteine proteases (35), consistent with the 
results described above. Recombinant Cwp84 is known to self-process (31), and the two labeled 
proteins may be intermediates on this pathway. CD1751 is a close homolog of Cwp84 (63% identity 
at the amino acid level), but the high sequence coverage achieved in these analyses (45%) rules out 
this protease as a candidate target. Three bands that are not labeled but that co-purify with labeled 
Cwp84 were identified as Cwp66, CD2767 and CD2797. cwp66 and CD2797  are part of the same 
gene cluster as slpA; Cwp66 has previously been described as a temperature-dependent adhesin (36), 
whilst CD2767 and CD2797 have no known function. 
The data described above provide convincing evidence that Cwp84 is the key target of the 
inhibitors and ABPs described herein. Furthermore, the close linkage between inhibition activity and 
labeling supports the hypothesis that Cwp84 is the protease responsible for S-layer processing in C. 
difficile. To confirm the on-target specificity of Cwp84 for SlpA we designed a construct (‘LHG’) 
containing SlpA residues 1-362 fused to a C-terminal GST tag (Fig. 3A). SlpA[1-362] includes the 
LMW SLP and the N-terminal part of the HMW SLP sufficient for interaction with the LMW SLP 
(termed the HMW interaction domain, HID, Fig. S6A) (7), and thus encompasses the SlpA cleavage 
site. Co-expression of His-tagged Cwp84 and LHG in E. coli on a dual expression plasmid resulted in 
cleavage of LHG to the LMW SLP and a GST-tagged fragment. These bands are not produced when 
LHG is co-expressed in the presence of a Cwp84 mutant in which the active site Cys identified by 
sequence homology was mutated to Ala (C116A) (Fig. 3B and Fig. S6B). N-terminal sequencing of 
each fragment demonstrated that Cwp84 cleaves this substrate at Ser321, i.e. at ...ETKS↓AND..., the 
same location observed in vivo in C. difficile strain 630 (Table S1) (33). The substrate selectivity of 
Cwp84 was then probed directly using this assay: seven LHG constructs bearing an alanine point 
mutation at the P6’ to P1’ or A322G at the P1 positions flanking the cleavage site were co-expressed in 
the presence of Cwp84 and tested for cleavage (Fig. 3C). A clear trend was observed: the only mutant 
that completely lacks cleavage is K320A (the P2’ position), confirming the key importance of this site 
for substrate recognition. Interestingly, T319A appears to reduce cleavage efficiency relative to the 
wild type site, and E318A appears to enhance it somewhat. Cwp84 was expressed at equivalent levels 
across these experiments (Fig. S7), strongly suggesting that these effects are directly due to 
differences in substrate affinity rather than variations in Cwp84 activity. 
^ FIGURE 3 
CONCLUSION 
Starting from the observation that SlpA is cleaved in vivo to generate the major structural components 
of the C. difficile surface layer, we have identified E-64 and 1 as the first inhibitors of this process, 
and reported the development of improved inhibitors 5, 9 and 13 with in vivo activity ranging down to 
low-µM concentration. These chemical genetic probes of S-layer formation have been used to 
demonstrate that full-length SlpA is poorly tolerated in the S-layer, leading to a marked reduction in 
cell integrity. Our results also point to a regulatory mechanism that drives increased SlpA expression 
in response to chemical inhibition of Cwp84, a remarkable observation in view of the already very 
high rate of S-layer synthesis in uninhibited cells. On the basis of the results presented here it is 
plausible that S-layer processing is regulated and concerted, and we speculate that it may be 
coordinated by a conserved protein complex. Alkyne-tagged and directly-labeled activity-based 
probes have been developed, enabling the target of these inhibitors to be identified as Cwp84 and 
providing the first reported example of the application of ABPs in C. difficile; the SlpA cleavage site 
has also been confirmed by an in vivo assay reconstituted in E. coli. The lack of a direct effect on cell 
growth even at high inhibitor concentrations suggests that Cwp84 may not be an essential gene under 
optimal growth conditions, and by extension that S-layer processing might not be essential for 
viability, at least in rich media. This hypothesis has recently been confirmed by a Cwp84 knockout 
strain of C. difficile, reported whilst this paper was in preparation (37). C. difficile 630 Δcwp84 is 
indeed viable in rich medium, but grows more slowly than wild-type 630 and displays significantly 
different colony morphology. Furthermore, the S-layer of this strain contains significant quantities of 
unprocessed SlpA, and the LMW and HMW SLPs are not observed. Taken together with the results 
we report here these data provide very strong evidence that the major role for Cwp84 in vivo lies in 
cleavage of SlpA during surface layer biogenesis, though our data do not preclude possible co-activity 
against extracellular matrix proteins (31). We have recently shown that another S-layer protein, 
CwpV, is cleaved post-translationally in strain 630 (38), but it is currently unknown whether Cwp84 
or another as yet unidentified protease is responsible for this processing. 
Cwp84 is highly conserved in C. difficile (39, 40), and our studies across multiple clinical 
strains demonstrate that Cwp84 expression, activity and function also appear to be highly conserved. 
However, CD1751, a homologue of Cwp84, was not detected in labeled samples, and does not appear 
to play a role in S-layer processing under standard culture conditions. The apparently canonical 
binding mode of E-64 derivatives for Cwp84 and our substrate specificity analyses provide in vivo 
evidence for classification of Cwp84 as a papain-class cysteine protease that possesses a key substrate 
recognition determinant at the P2’ position. It is interesting to note that this enzyme appears to accept 
substrates with residues of contrasting chemical character (either aromatic or charged) at P2 (23, 24), 
whilst most other residues are excluded on the basis of our inhibition and labeling data. Furthermore, 
certain ABPs described here (13 and 18) appear to intercept Cwp84 at multiple stages of self-
processing in a structure-dependent fashion, presenting a potential tool for analysis of Cwp84 
activation in vivo.  
The marked effect of Cwp84 inhibition on cell integrity as judged by susceptibility to lysis 
might be expected to lead to strong effects on viability under conditions of stress (e.g. antibiotic 
treatment, attack by the host immune system), and warrants further investigation of S-layer processing 
as a potential therapeutic target. The data presented here also demonstrate that Cwp84 is readily 
accessible to inhibitors in the medium, circumventing issues of intracellular uptake through the dense 
S-layer. Weakening of the S-layer by this mechanism might also result in improved penetration of co-
administered antibiotics, and it will be interesting to see whether Cwp84 inhibitors can act 
synergistically with such agents. The inhibitors and ABPs described here represent useful and novel 
tools for studying cell wall biogenesis in C. difficile, and provide a unique approach for the detection 
of active Cwp84 in live cells. Work is ongoing in our labs to exploit these probes for the further 
investigation of these processes, and their extension to related pathogenic organisms. 
METHODS 
C. difficile strains. C. difficile 630 has been fully sequenced (35). R8366, R7404, Y, CDKK167 and 
CDKK959 have been described previously (23, 33). R13541 was obtained from De´ irdre Nı´ Eidhin 
(Trinity College, Dublin) and SE528 from Dr Michelle Delemee, Universite´ Catholique de Louvain, 
Brussels. 
C. difficile culture conditions. C. difficile was routinely cultured either on blood agar base II (Oxoid 
Ltd, Basingstoke, UK) supplemented with 7% horse blood (TCS Biosciences, Botolph Claydon, UK); 
or in brain-heart infusion (BHI) broth (Oxoid). Culture was undertaken in an anaerobic cabinet (Don 
Whitley Scientific, Shipley, UK) at 37 ºC in a reducing anaerobic atmosphere (10% CO2, 10% H2, 
80% N2). Glycine extracts were prepared as described previously (33). 
In vivo inhibition assay.  A single colony of C. difficile was inoculated in BHI broth and grown 
anaerobically for 1 hour.  The culture was aliquoted, and bacteria were grown in the presence of each 
inhibitor overnight (16-18 hours). The cells were harvested by centrifugation, resuspended in SDS-
PAGE loading buffer, boiled and analyzed by SDS-PAGE and western blotting. All assays used strain 
630, unless otherwise specified. 
SlpA cleavage assay in E. coli. A derivative of SlpA was co-expressed in E. coli with Cwp84 to 
assay cleavage activity. Residues 1-362 of SlpA were cloned as a fusion with glutathione-S-
transferase in MCS2 of pACYCDuet-1 (Novagen). Residues 30-803 of Cwp84 were then cloned in 
the MCS1 of the same plasmid to form the co-expression plasmid. Derivatives of Cwp84 and LHG 
containing amino acid substitutions were created using inverse PCR.  E. coli cells were grown in LB-
broth with chloramphenicol (30 µg ml-1) and glucose (0.5%) to OD 0.7, IPTG added to 120 µM and 
induction continued for 24 hours. Cell lysates were prepared and analyzed by SDS-PAGE and western 
blotting using anti-LMW SLP (1 in 400,000) and anti-GST antibodies (1 in 4,000). Pull-downs using 
glutathione sepharose 4B matrix was performed according to the manufacturer’s protocol 
(Amersham). 
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Scheme 1. Overview of the three-stage maturation of SlpA in C. difficile to generate the S-layer 
protein complex. A: removal of the signal peptide by signal peptidase; B: cleavage by a protease 
(identified herein as Cwp84), to generate the high and low molecular weight surface layer proteins 
(HMW and LMW SLPs); C: re-association of LMW and HMW SLPs to form the S-layer matrix. 
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Fig. 1 Structures of inhibitors and ABPs synthesized in this study 
A: structures of E-64, synthetic inhibitors and ABPs 1-18 used in this study; B: activity of E-64, 1 and 
2, as measured by Western blot of S-layer fractions using anti-LMW SLP. C. difficile 630 cultures 
were treated with compound at 100 µM during overnight growth under anaerobic conditions in Brain 
Heart Infusion (BHI) medium, followed by isolation of the S-layer fraction as described (7). 
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Fig. 2 In vivo activity and labeling by ABPs in C. difficile S-layer processing 
A: activity across ABP series 3-16, visualized by Western blot using anti-LMW SLP; 
B: concentration series for 3 (S-layer and culture supernatant) and 9 (S-layer), SlpA visualized as for 
A; C: labeling across ABP series 3-16, as revealed by in-gel fluorescence after CuAAC ligation to a 
fluorescent reporter; D: activity of biotinylated ABPs 17 and 18; E: NeutrAvidin-HRP blots (NB) and 
coomassie-stained gels (C) of glycine extracts labeled by 17 and 18, showing proteins after  affinity-
purification (pull-down) with NeutrAvidin-agarose; a representative supernatant after pull-down 
following treatment of cells with 17 is also shown. The marked bands were identified as: 1, SlpA; 2, 
CD2791; 3, HMW SLP; 4. LMW SLP; 5. CD2797; 6. Cwp84; 7. Cwp66; 8. CD2767. See supporting 
information for further details. 
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Fig. 3 Model cleavage assay for SlpA reconstituted in E. coli.  
A: LHG construct; B: LHG processing in E. coli co-expressing LHG (all lanes) and either Cwp84 
(lanes 1, 3, 5) or Cwp84[C116A] (lanes 2, 4); cells were lysed 24 hours post-induction, and soluble 
protein visualized by Western blot using anti- αLMW SLP (lanes 1, 2) or anti-GST (lanes 3, 4). Lane 
5 shows coomassie-stained proteins following affinity purification by pull-down onto glutathione 
sepharose beads; N-terminal sequencing of the HID-GST band excised from the gel shown in lane 5 
confirmed the cleavage site as ...ETKS↓ANDTIA...; C: in vivo cleavage assay for LHG constructs by 
Cwp84 containing a point mutations at the P6’ to P1 sites flanking the scissile bond.  
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